Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001387131-17-003715
Filing Date
2017-07-20
Accepted
2017-07-20 16:49:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424(B)(3) admp-424b3_071917.htm 424B3 17309
2 GRAPHIC image_001.jpg GRAPHIC 4122
  Complete submission text file 0001387131-17-003715.txt   24222
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-196976 | Film No.: 17974733
SIC: 2834 Pharmaceutical Preparations